RDInvesting Provides Stock Research on Ford and General Motors
Continue ReadingTag: research-driven-investing
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
RDInvesting Provides Stocks Research on Exelixis and Novogen
Continue Reading
Improvements in the U.S. Economy to Keep Vehicle Sales Climbing in 2013
RDInvesting Provides Stock Research on Honda and Toyota
Continue Reading
Talks of a Potential Merger Between Office Depot and OfficeMax Sends Office Retailers Soaring
RDInvesting Provides Stock Research on Staples and Amazon
Continue Reading
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
RDInvesting Provides Stocks Research on ImmunoCellular Therapeutics and Rosetta Genomics
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
RDInvesting Provides Stocks Research on Ariad Pharmaceuticals and Infinity Pharmaceuticals
Continue Reading
Major Health Insurers Fall on Medicare Rate Cut Proposal
RDInvesting Provides Stock Research on Aetna and WellCare Health Plans
Continue Reading
Humana and UnitedHealth Group Shares Fall as Government Proposes Medicare Advantage Rate Cuts
RDInvesting Provides Stock Research on Humana and UnitedHealth Group
Continue Reading
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
RDInvesting Provides Stocks Research on Opko Health and Questcor Pharmaceuticals
Continue Reading
Solar Industry Impressing Investors With Gains in 2013 After a Dismal 2012
RDInvesting Provides Stock Research on Canadian Solar and JA Solar
Continue Reading